$XXII
22nd Century Group, Inc. Stock $xxii

$xxii Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000114420416117680 Filed on August 09, 2016

Income Statement

Concept	2016 Q2	2015 Q4	2015 Q2
Revenue	$2.828M	$2.931M	$2.307M
YoY Change	22.57%	321678.38%	14216.45%
Cost Of Revenue	$2.969M	$2.920M	$2.600M
YoY Change	14.16%		19636.23%
Gross Profit	-$140.9K	$10.80K	-$293.5K
YoY Change	-51.99%	-1439.33%	-10089.55%
Gross Profit Margin	-4.98%	0.37%	-12.72%
Selling, General & Admin	$1.973M	$2.010M	$1.588M
YoY Change	24.25%	-61.12%	15.16%
% of Gross Profit		18619.73%
Research & Development	$509.9K	$650.0K	$283.6K
YoY Change	79.81%	71.05%	7.7%
% of Gross Profit		6021.31%
Depreciation & Amortization	$81.07K	$200.0K	$78.63K
YoY Change	3.1%	33.33%	5.29%
% of Gross Profit		1852.71%
Operating Expenses	$2.690M	$2.840M	$2.060M
YoY Change	30.59%	-50.35%	0.91%
Operating Profit	-$2.831M	-$2.830M	-$2.347M
YoY Change	20.63%	-50.5%	15.14%
Interest Expense	$9.322K	-$20.00K	$13.75K
YoY Change	-32.22%	-115.38%	677.44%
% of Operating Profit
Other Income/Expense, Net	-$71.52K	$0.00	$1.065M
YoY Change	-106.72%		1371.44%
Pretax Income	-$2.902M	-$2.860M	-$1.289M
YoY Change	125.22%	-48.84%	-34.58%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.902M	-$2.865M	-$1.289M
YoY Change	125.22%	-48.75%	-34.44%
Net Earnings / Revenue	-102.64%	-97.73%	-55.86%
Basic Earnings Per Share
Diluted Earnings Per Share	-$38.15K	-$40.34K	-$19.36K
COMMON SHARES
Basic Shares Outstanding	76.02M shares	70.97M shares	66.62M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q2	2015 Q4	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.840M	$3.760M	$8.200M
YoY Change	-65.37%	-41.25%	96.64%
Cash & Equivalents		$3.760M	$8.197M
Short-Term Investments
Other Short-Term Assets	$720.0K	$710.0K	$460.0K
YoY Change	56.52%	-67.58%	84.0%
Inventory	$3.147M	$2.706M	$2.382M
Prepaid Expenses
Receivables	$105.7K	$51.23K	$449.5K
Other Receivables	$0.00	$0.00	$600.0K
Total Short-Term Assets	$6.811M	$7.228M	$12.13M
YoY Change	-43.85%	-32.49%	95.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.415M	$2.556M	$2.716M
YoY Change	-11.09%	-10.34%	-7.94%
Goodwill
YoY Change
Intangibles	$7.385M	$7.364M	$7.206M
YoY Change	2.49%	4.05%
Long-Term Investments	$1.081M	$1.223M	$1.230M
YoY Change	-12.15%	-7.37%	392.0%
Other Assets
YoY Change
Total Long-Term Assets	$10.88M	$11.07M	$11.15M
YoY Change	-2.4%	-1.58%	438.35%
TOTAL ASSETS
Total Short-Term Assets	$6.811M	$7.228M	$12.13M
Total Long-Term Assets	$10.88M	$11.07M	$11.15M
Total Assets	$17.69M	$18.30M	$23.28M
YoY Change	-24.0%	-16.66%	107.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.567M	$1.283M	$984.7K
YoY Change	59.18%	45.11%	34.89%
Accrued Expenses	$1.191M	$1.349M	$1.149M
YoY Change	3.7%	24.77%	74.04%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$170.0K
YoY Change	-100.0%	-100.0%	0.0%
Long-Term Debt Due	$320.0K	$310.0K	$330.0K
YoY Change	-3.03%	-3.13%
Total Short-Term Liabilities	$3.305M	$3.162M	$2.927M
YoY Change	12.9%	18.28%	87.46%
LONG-TERM LIABILITIES
Long-Term Debt	$310.0K	$310.0K	$610.0K
YoY Change	-49.18%	-49.18%
Other Long-Term Liabilities	$120.0K	$3.100M	$3.180M
YoY Change	-96.23%	-10.4%	478.18%
Total Long-Term Liabilities	$430.0K	$3.410M	$3.790M
YoY Change	-88.65%	-16.22%	589.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.305M	$3.162M	$2.927M
Total Long-Term Liabilities	$430.0K	$3.410M	$3.790M
Total Liabilities	$3.729M	$6.568M	$6.710M
YoY Change	-44.42%	-2.46%	217.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$72.71M	-$66.56M	-$60.93M
YoY Change	19.34%	19.87%	29.06%
Common Stock	$760.00	$710.00	$708.00
YoY Change	7.34%	10.76%	19.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.96M	$11.73M	$16.57M
YoY Change
Total Liabilities & Shareholders Equity	$17.69M	$18.30M	$23.28M
YoY Change	-24.0%	-16.66%	107.09%

Cashflow Statement

Concept	2016 Q2	2015 Q4	2015 Q2
OPERATING ACTIVITIES
Net Income	-$2.902M	-$2.865M	-$1.289M
YoY Change	125.22%	-48.75%	-34.44%
Depreciation, Depletion And Amortization	$81.07K	$200.0K	$78.63K
YoY Change	3.1%	33.33%	5.29%
Cash From Operating Activities	-$3.090M	-$2.460M	-$1.080M
YoY Change	186.11%	-11.51%	-2.7%
INVESTING ACTIVITIES
Capital Expenditures	-$100.0K	-$110.0K	-$140.0K
YoY Change	-28.57%	-59.26%	180.0%
Acquisitions
YoY Change
Other Investing Activities	-$20.00K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$120.0K	-$110.0K	-$140.0K
YoY Change	-14.29%	-86.75%	-64.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-410.0K	5.570M
YoY Change	-100.0%		1756.67%
NET CHANGE
Cash From Operating Activities	-3.090M	-2.460M	-1.080M
Cash From Investing Activities	-120.0K	-110.0K	-140.0K
Cash From Financing Activities	0.000	-410.0K	5.570M
Net Change In Cash	-3.210M	-2.980M	4.350M
YoY Change	-173.79%	-17.45%	-462.5%
FREE CASH FLOW
Cash From Operating Activities	-$3.090M	-$2.460M	-$1.080M
Capital Expenditures	-$100.0K	-$110.0K	-$140.0K
Free Cash Flow	-$2.990M	-$2.350M	-$940.0K
YoY Change	218.09%	-6.37%	-11.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	635998	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2414726	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2555793	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7385456	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	3146933	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	717478	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	13962103	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17691479	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7364120	USD
CY2016Q2	us-gaap	Equity Method Investments EquityMethodInvestments	1080580	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5846714	USD
	us-gaap	Gross Profit GrossProfit	-309935	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2923091	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3233026	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5863981	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6480522	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6059234	USD
	xxii	Gain Loss From Warrant Liability GainLossFromWarrantLiability	171833	USD
	xxii	Gain Loss From Warrant Liability GainLossFromWarrantLiability	61597	USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-91815	USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-142071	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5405442	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6154806	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65408908	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75027606	shares
	us-gaap	Depreciation Depreciation	161664	USD
	us-gaap	Depreciation Depreciation	157440	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6154806	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	250882	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	216289	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Interest Expense InterestExpense	19696	USD
	us-gaap	Interest Expense InterestExpense	19261	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	4598	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	14323	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2600446	USD
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	199658	USD
CY2016Q2	xxii	Accrued Severance Liabilities Current AccruedSeveranceLiabilitiesCurrent	225117	USD
CY2015Q4	xxii	Accrued Severance Liabilities Current AccruedSeveranceLiabilitiesCurrent	220661	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	2706330	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	105729	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51230	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	6810717	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	7153855	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2306953	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2827658	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1191219	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2968571	USD
CY2016Q2	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	90101	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5405442	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5091791	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	486422	USD
	xxii	Stock Issued During Period Warrants Excercised Value StockIssuedDuringPeriodWarrantsExcercisedValue	196	USD
	xxii	Adjustment To Additional Paid In Capital Warrant Liability Reclassified AdjustmentToAdditionalPaidInCapitalWarrantLiabilityReclassified	2810000	USD
	xxii	Amortization Of License Fees AmortizationOfLicenseFees	49011	USD
	xxii	Amortization Of License Fees AmortizationOfLicenseFees	49011	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	685860	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	472216	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2113003	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	30873	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	377127	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	440603	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	174489	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	98146	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-123334	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	112862	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	392123	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3604029	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	4631	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-143502	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	196	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5541583	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	54499	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1794052	USD
	xxii	Increase Decrease In Accrued Severance IncreaseDecreaseInAccruedSeverance	-112501	USD
	xxii	Increase Decrease In Accrued Severance IncreaseDecreaseInAccruedSeverance	-30857	USD
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	0	USD
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	34500	USD
	xxii	Inventory Reserve Adjustments InventoryReserveAdjustments	-60000	USD
	us-gaap	Accretion Expense AccretionExpense	19696	USD
	us-gaap	Accretion Expense AccretionExpense	11984	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	363535	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	324718	USD
CY2016Q2	us-gaap	Assets Assets	17691479	USD
CY2015Q4	us-gaap	Assets Assets	18296419	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1567424	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1283346	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1349438	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3304638	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3162027	USD
CY2016Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	26699	USD
CY2015Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2898296	USD
CY2016Q2	us-gaap	Liabilities Liabilities	3729376	USD
CY2015Q4	us-gaap	Liabilities Liabilities	6567919	USD
CY2015Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1222651	USD
CY2016Q2	xxii	Assests Noncurrent Excluding Property Plant And Equipment Net AssestsNoncurrentExcludingPropertyPlantAndEquipmentNet	8466036	USD
CY2015Q4	xxii	Assests Noncurrent Excluding Property Plant And Equipment Net AssestsNoncurrentExcludingPropertyPlantAndEquipmentNet	8586771	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72711831	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-66557025	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	11728500	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18296419	USD
CY2016Q2	us-gaap	Notes Payable Current NotesPayableCurrent	320878	USD
CY2015Q4	us-gaap	Notes Payable Current NotesPayableCurrent	308582	USD
CY2016Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	307938	USD
CY2015Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	307938	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	78284815	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	760	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	86673174	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-2902354	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	442069	USD
	us-gaap	Gross Profit GrossProfit	-17267	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	-140913	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	283600	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	509928	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2353264	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2830830	USD
CY2015Q2	xxii	Gain Loss From Warrant Liability GainLossFromWarrantLiability	112620	USD
CY2016Q2	xxii	Gain Loss From Warrant Liability GainLossFromWarrantLiability	-9468	USD
CY2015Q2	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-40834	USD
CY2016Q2	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-54839	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-1288703	USD
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66616739	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76024064	shares
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1721775	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1297064	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	251106	USD
CY2015Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	290775	USD
CY2016Q2	us-gaap	Depreciation Depreciation	81067	USD
CY2015Q2	us-gaap	Depreciation Depreciation	78630	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2902354	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1288703	USD
CY2016Q2	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	126041	USD
CY2015Q2	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	109702	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	9322	USD
CY2016Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2105	USD
CY2015Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	6528	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	-293493	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	61597	USD
	xxii	Inventory Reserve Adjustments InventoryReserveAdjustments	0	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-158219	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5890107	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	20596	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-121600	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5091987	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	449461	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-919720	USD
CY2015Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3016246	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	555814	USD
CY2015Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	95361	USD
	us-gaap	Interest Paid Net InterestPaidNet	19696	USD
	us-gaap	Interest Paid Net InterestPaidNet	7296	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2015Q4	xxii	Inventory Tobacco Leaf Gross InventoryTobaccoLeafGross	1816857	USD
	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	171215	USD
	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	205586	USD
	xxii	Machinery And Equipment Additions Included In Accounts Payable MachineryAndEquipmentAdditionsIncludedInAccountsPayable	0	USD
	xxii	Machinery And Equipment Additions Included In Accounts Payable MachineryAndEquipmentAdditionsIncludedInAccountsPayable	18000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	325000	USD
CY2015Q2	us-gaap	Cash Cash	8196739	USD
CY2014Q4	us-gaap	Cash Cash	6402687	USD
CY2016Q2	xxii	Inventory Tobacco Leaf Gross InventoryTobaccoLeafGross	1842822	USD
CY2016Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	110623	USD
CY2015Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	110623	USD
CY2016Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	560819	USD
CY2015Q4	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	342707	USD
CY2016Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	853915	USD
CY2015Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	657389	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	250882	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	216289	USD
	xxii	Percentage Of Net Loss PercentageOfNetLoss	0.25	pure
CY2014Q2	us-gaap	Equity Method Investments EquityMethodInvestments	250000	USD
CY2014	xxii	Finite Lived Intangible Assets Acquired With Notes Payable FiniteLivedIntangibleAssetsAcquiredWithNotesPayable	925730	USD
CY2014Q4	us-gaap	Other Commitment OtherCommitment	1213000	USD
CY2016Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	628816	USD
CY2015Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	616520	USD
CY2014Q4	us-gaap	Severance Costs1 SeveranceCosts1	624320	USD
CY2014Q4	xxii	Severance Term SeveranceTerm	P36M
CY2014Q4	xxii	Accrued Severance Liabilities Current AccruedSeveranceLiabilitiesCurrent	212012	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	412308	USD
CY2016Q1	xxii	Warrant Exercisable Per Share WarrantExercisablePerShare	3.36
CY2015Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	242658	USD
CY2015	xxii	Percentage Of Orders Shipped PercentageOfOrdersShipped	0.4	pure
CY2016Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	329321	USD
CY2016Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2618	shares
CY2016Q1	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	67042	shares
CY2016Q1	xxii	Warrants Expired And Unexercised WarrantsExpiredAndUnexercised	6831115	shares
CY2016Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10236621	shares
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10653469	shares
CY2014	xxii	Warrants Issued In Conjunction With Consulting Agreement WarrantsIssuedInConjunctionWithConsultingAgreement	4250000	shares
CY2014	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	1247443	shares
CY2014	xxii	Common Stock Warrants Issued Additional Number CommonStockWarrantsIssuedAdditionalNumber	18383	shares
CY2015	xxii	Common Stock Warrants Issued Additional Number CommonStockWarrantsIssuedAdditionalNumber	369	shares
	xxii	Warrants With Provision Of Anti Dilution WarrantsWithProvisionOfAntiDilution	92632	shares
	xxii	Warrants Without Provision Of Anti Dilution WarrantsWithoutProvisionOfAntiDilution	10143989	shares
CY2015	xxii	Warrants Issued In Conjunction With Registered Direct Offering WarrantsIssuedInConjunctionWithRegisteredDirectOffering	3000000	shares
CY2014Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13674409	shares
	xxii	Warrants Issued In Conjunction With Registered Direct Offering WarrantsIssuedInConjunctionWithRegisteredDirectOffering	2500000	shares
	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	67042	shares
	xxii	Number Of Warrants Expired NumberOfWarrantsExpired	6831115	shares
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	16634778	shares
	xxii	Unexercisable Warrants UnexercisableWarrants	2000000	shares
CY2014	xxii	Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants	7367915	USD
CY2014	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	3676691	USD
CY2014	xxii	Inducement Costs From Warrant Amendments InducementCostsFromWarrantAmendments	144548	USD
CY2015	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	144550	USD
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	61597	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3042846	USD
	xxii	Reclassification Of Warrant Liability To Capital In Excess Of Par Value ReclassificationOfWarrantLiabilityToCapitalInExcessOfParValue	2810000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	171833	USD
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	75027606	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	65408908	shares
CY2016Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0138	pure
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P8Y7M28D
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	300000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	890000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3161642	shares
CY2015	xxii	Share Based Compensation Arrangement By Sharebased Payment Award Options Reinstated In Period ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsReinstatedInPeriod	50000	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2221642	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2511642	shares
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.61
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.015	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.9	pure
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.9	pure
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P5Y11D
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.69
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.1
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.38
CY2015	xxii	Share Based Compensation Arrangements By Share Based Payment Award Options Reinstated In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsReinstatedInPeriodWeightedAverageExercisePrice	0.69
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.15
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1824037	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.94
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4985679	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	92450	USD
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	56950	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	660000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.74
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.64
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.59
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1824037	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1721642	shares
CY2016Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1327000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	156000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	169000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	169000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	169000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	141000	USD
CY2015Q4	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	3750	USD
CY2015Q4	us-gaap	Land Subject To Ground Leases LandSubjectToGroundLeases	25000	acre
	xxii	Lease Payments LeasePayments	72262	USD
	xxii	Lease Payments LeasePayments	61500	USD
CY2014Q1	us-gaap	License Costs LicenseCosts	85681	USD
	xxii	Milestone Payment MilestonePayment	150000	USD
CY2015Q4	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	75000	USD
CY2015Q4	us-gaap	License Costs LicenseCosts	150000	USD
CY2016Q2	xxii	Minimum Annual Royalties In Year Five MinimumAnnualRoyaltiesInYearFive	25000	USD
CY2016Q2	xxii	Minimum Annual Royalties After Year Five MinimumAnnualRoyaltiesAfterYearFive	50000	USD
CY2016Q2	xxii	Minimum Annual Royalties In Year Three MinimumAnnualRoyaltiesInYearThree	10000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	22nd Century Group, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001347858
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Trading Symbol TradingSymbol	XXII
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82198113	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	76025273	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76025273	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71066844	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71066844	shares
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	2689917	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	2059771	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-71524	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1064561	USD
CY2016Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2015Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1000000	USD
	us-gaap	Operating Expenses OperatingExpenses	6041967	USD
	us-gaap	Operating Expenses OperatingExpenses	6170587	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-95572	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1075080	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	0	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	600000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	101004	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	138871	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 34.1pt; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 37.4pt; MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Reclassifications</font></i></strong><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">-</font></i> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Certain items in the 2015 financial statements have been reclassified to conform to the 2016 classification.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 37.4pt; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 37.4pt; MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Use of Estimates</font></i></strong><strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">-</font></strong> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	74000	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3779522	USD
CY2016Q2	xxii	Warrants Outstanding WarrantsOutstanding	10236621	shares
CY2015Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	112620	USD
CY2016Q2	xxii	Inventorytobacco Leaf Net InventorytobaccoLeafNet	3257556	USD
CY2015Q4	xxii	Inventorytobacco Leaf Net InventorytobaccoLeafNet	2816953	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	126041	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	109702	USD
CY2016Q2	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1842000	USD
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	3577000	USD
CY2015Q2	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1603000	USD
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1928000	USD
CY2016Q2	us-gaap	Advertising Expense AdvertisingExpense	27000	USD
	us-gaap	Advertising Expense AdvertisingExpense	235000	USD
CY2015Q2	us-gaap	Advertising Expense AdvertisingExpense	64000	USD
	us-gaap	Advertising Expense AdvertisingExpense	115000	USD
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y1M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1138910	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	206500	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	212222	USD
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	331773	USD
CY2016Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	19076	USD
CY2015Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	0	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3132204	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3111607	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19436420	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15222300	shares
CY2016Q2	xxii	Lease Payments LeasePayments	36131	USD
CY2015Q2	xxii	Lease Payments LeasePayments	30750	USD
	us-gaap	Research And Development Arrangement Contract To Perform For Others Description And Terms ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms	12 months
CY2016Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-9468	USD
CY2016Q2	xxii	Minimum Annual Royalties In Year Four MinimumAnnualRoyaltiesInYearFour	15000	USD
CY2016Q2	xxii	Litigation Settlement Shares To Be Issued LitigationSettlementSharesToBeIssued	2077555	shares
CY2016Q2	xxii	Minimum Royalty Fee Payments Due In Year Four MinimumRoyaltyFeePaymentsDueInYearFour	15000	USD

Files In Submission

Name	View Source	Status
0001144204-16-117680-index-headers.html	Edgar Link	pending
0001144204-16-117680-index.html	Edgar Link	pending
0001144204-16-117680.txt	Edgar Link	pending
0001144204-16-117680-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v445292_10q.htm	Edgar Link	pending
v445292_ex31-1.htm	Edgar Link	pending
v445292_ex31-2.htm	Edgar Link	pending
v445292_ex32-1.htm	Edgar Link	pending
xxii-20160630.xml	Edgar Link	completed
xxii-20160630.xsd	Edgar Link	pending
xxii-20160630_cal.xml	Edgar Link	unprocessable
xxii-20160630_def.xml	Edgar Link	unprocessable
xxii-20160630_lab.xml	Edgar Link	unprocessable
xxii-20160630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XXII
22nd Century Group, Inc. Stock $xxii

2016 Q2 Form 10-Q Financial Statement

#000114420416117680 Filed on August 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII 22nd Century Group, Inc. Stock $xxii

2016 Q2 Form 10-Q Financial Statement

#000114420416117680 Filed on August 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII
22nd Century Group, Inc. Stock $xxii